Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Adc Therapeutics SA shares valued at $304,500 were purchased by Redmile Group, LLC on Dec 11 ’24. At $3.04 per share, Redmile Group, LLC acquired 100,000 shares. The insider’s holdings grew to 15,666,731 shares worth approximately $30.08 million following the completion of this transaction.
Also, Redmile Group, LLC purchased 100,000 shares, netting a total of over 304,500 in proceeds. Following the buying of shares at $3.04 each, the insider now holds 13,145,712 shares.
Before that, Redmile Group, LLC had sold 25,352 shares from its account. In a trade valued at $52,479, the 10% Owner traded Adc Therapeutics SA shares for $2.07 each. Upon closing the transaction, the insider’s holdings decreased to 25,352 shares, worth approximately $29.89 million.
As published in their initiating research note from Stephens on November 08, 2024, Adc Therapeutics SA [ADCT] has been an Overweight and the price target has been revised to $6. Analysts at Cantor Fitzgerald started covering the stock with ‘”an Overweight”‘ outlook in a report released in late May. As of March 28, 2024, Guggenheim has initiated its “Buy” rating for ADCT. Earlier on August 10, 2023, JP Morgan upgraded its rating. Their new recommendation was “a Neutral” for ADCT stock which previously was a “an Underweight”.
Analyzing ADCT Stock Performance
During the last five days, there has been a drop of approximately -3.52%. Over the course of the year, Adc Therapeutics SA shares have dropped approximately -3.52%. Shares of the company reached a 52-week high of $2.20 on 01/02/25 and a 52-week low of $1.91 on 01/08/25. A 50-day SMA is recorded $2.38, while a 200-day SMA reached $3.23. Nevertheless, trading volume fell to 0.39 million shares from 0.67 million shares the previous day.
Support And Resistance Levels for Adc Therapeutics SA (ADCT)
According to the 24-hour chart, there is a support level at 1.89, which, if violated, would cause prices to drop to 1.85. In the upper region, resistance lies at 1.98. The next price resistance is at 2.03. RSI (Relative Strength Index) is 43.69 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.04, which suggests the price will decrease in the coming days. Percent R is at 90.63%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
